phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Researchers Find New Target to Sensitize Pancreatic Tumors to Immunotherapy

* DPY30 acts as an epigenetic regulator to help pancreatic tumors maintain genomic stability * Targeting DPY30 triggers immune cell infiltration and sensitizes tumors to immunotherapy * DPY30 expression could predict which patients are more likely to benefit from immunotherapy * Therapeutic strategies could combine DPY30 inhibition with immunotherapy to improve patient outcomes

April 8, 2026


April 10 2026

April 9 2026

April 8 2026

April 7 2026

April 6 2026

April 5 2026

April 4 2026

April 3 2026

April 2 2026

April 1 2026

March 31 2026

March 30 2026

March 29 2026

March 28 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy